Management of women at increased risk for breast cancer: Preliminary results from a new program

CMAJ. Canadian Medical Association Journal

Volumn 157, Issue 9, 1997, Pages 1235-1242

  Chart, Pamela L ^a   Franssen, Edmée ^a,b  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST EXAMINATION; CANCER RISK; CANCER SCREENING; CLINICAL ARTICLE; CLINICAL FEATURE; CONSULTATION; EARLY DIAGNOSIS; FAMILY HISTORY; FEMALE; GENETICS; HIGH RISK PATIENT; HUMAN; MAMMOGRAPHY; PSYCHOSOCIAL CARE; SELF EXAMINATION;

EID: 0030697174     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. The Workshop Group. Reducing deaths from breast cancer in Canada. Can MfdAssocJ 19S9;141:199-201.
2. Fletcher SW, Black W, Harris R, Rimmer BK, Shapiro S. Workshop report: International Workshop on Screening for Breast Cancer. Bethesda (AID): National Cancer Institute; 1993.
3. Smart CR, Hendrick RE, Rutledge JH III, Smith RA. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer 1995;75:1619-26.
4. Nelson NJ. The Mammography Consensus Jury speaks out. J Nail Cancer Inn 1997;89:344-7.
5. Eastman P. NCI adopts new mammography screening guidelines for women. 7 \atl Cancer Inst 1997;89:53 8-40.
6. Cohen MI, Alintzer RA, Alatthies IIJ, Bernstein JR. Alammography in women less than 40 years of age. Snrg Gynecol Obstet 1985;! 60:220-2.
7. Aleyer JE, Kopans DB, Out R. Breast cancer visualized by mammography in patients under 35. Radiology 1983;147:93-4.
8. Schecter AIT, Aliller AB, Baines CJ, Howe GR. Selection of women at high risk of breast cancer for initial screening. J Chronic Dis 1986;39:2S3-60.
9. Kamb A, Skolnick AIH. Identification of the BRCA1 breast cancer gene and its clinical implications. In: DeVîta VT, Hellman S, Rosenberg SA, editors. Important advances in oncology. Philadelphia: Lippincott-Raven Publishers; 1996:23-5.
10. Weber BL. Clinical implications of basic research, susceptibility genes for breast cancer. XEnglJMed 1994;331:1523-4.
11. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar D, the Breast Cancer Linkage Consortium. Risks of cancer in Z?SCH/-mutation carriers. Lancet I994;343:692-5.
12. Biesccker BB, Boehnke AI, Calzone K, Markel DS, Garber JE, Collins FS, et al. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 1993;269:1970-4.
13. Botkin JR, Croyle RT, Smith KR, Baty BJ, Lerman C, Goldgar DE, et al. A model protocol for evaluating the behavioral and psychosocial effects of BRCAl testing. JNatl Cancer Inst 1996;88:872-81.
14. Houlston RS, Lemoine L, AlcCarter E, Harrington S, AlacDermot K, Hinton J, et al. Screening and genetic counselling for relatives of patients with breast cancer in a family cancer c\\n\c,J Med Genet 1992;29:691-4.
15. Alorrow AI. Identification and management of women at increased risk for breast cancer development. Breast Cancer Res Treat 1994;31:53-60.
16. Dershaw DD, Yahalom J, Petrek JA. Breast carcinoma in women previously treated for Hodgkin disease: mammographie evaluation. Radiology 1992; 184: 421-3.
17. Aliller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years [published correction appears in Can Med Assoc J 1993;148:718]. Can MedAssocJ 1992;147:1459-76.
18. Aliller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years [published correction appears in Can A led Assoc J 1993;I48:718). Can Med Assoc J 1992;147:1477-88.
19. Baines CJ, Aliller AB, Bassett AA. Physical examination -its role as a single screening modality in the Canadian National Breast Screening Study. Cancer I989;63:1816-22.
20. Ontario Breast Screening Program Results 1990-93 (unpublished). Toronto: Ontario Cancer Treatment and Research Foundation.
21. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer I978;42:737-69.
22. O'Alalley AIS, Fletcher SW. Screening for breast cancer with breast self-examination. A critical review. JAMA 1987;257:2197-202.
23. Gastrin G, Miller AB, To T, Aronson KJ, Wall C, Hakama AI, et al. Incidence and mortality from breast cancer in the Alama Program for breast screening in Finland, 1973-1986. Cancer 1994;73:2168-74.
24. Gail AIH, Brinton LA, Byar DP, Corle DK, Green SB, schairer C, et al. Projecting individualized probabilities of developing breastacancer for white females who are being examined annuatiy. J Xatl Cancer Jnst 1989;81:1879-86.
25. Claus EB, Risch N, Thompson \\TJ. Autosomal dominant inheritance of early-onset breast cancer -implications for risk prediction. Cancer 1994; 73:643-51.
26. AIcGuigan KA, Ganz PA, Breant C. Agreement between breast cancer risk estimation methods. J'Nail Cancer Inst 1996;88:1315-7.
27. Becher H, Chang-Claude J. Estimating disease risks for individuals with a given family history in different populations with an application to breast cancer. Genet Epidmiiol 1996;13:229-42.
28. Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbecfc TR, Garber JE, et al. Assessment and counseling for women with a family history of breast cancer -a guide for clinicians. JAMA 1995;273:577-85.
29. Tabar L, Fagerberg G, Day NE, Duffy SW, Kitchin RAI. Breast cancer treatment and natural history: new insights from results of screening. Lancet 1992; 339:412-4.